Pathogenesis of venous thrombosis: A new insight

Vascular

Volumn 5, Issue 1, 1997, Pages 6-15

  Wakefield, T W ^a   Strieter, R M ^b   Prince, M R ^a   Downing, L J ^a   Greenfield, L J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

cytokine; inflammation; leukocyte; thrombosis; venous

Indexed keywords

CATHEPSIN G; CYTOKINE; DEXTRAN SULFATE; HEPARIN; PADGEM PROTEIN;

ENDOTHELIUM; HUMAN; LEUKOCYTE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THROMBOPHLEBITIS; VEIN THROMBOSIS;

CHEMOKINES; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; NEUTROPHIL ACTIVATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOPHLEBITIS; VENOUS INSUFFICIENCY;

EID: 0030977998     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099700500103     Document Type: Review

References (99)

1. Coon W. W., Epidemiology of venous thromboembolism. Annals of Surgery, 1977, 186, 149–164.
2. Anderson F. A., Wheeler H. B., Goldberg R. J., et al, A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Archives of Internal Medicine, 1991, 151, 933–938.
3. Stewart G. J., Neutrophils and deep venous thrombosis. Haemostasis, 1993, 23, 127–140.
4. Schaub R. G., Simmons C. A., Koets M. H., Romano J. P. II, Stewart G. J., Early events in the formation of a venous thrombus following local trauma and stasis. Laboratory Investigations, 1984, 51, 218–224.
5. Simmons C. A., Burdick M. D., Schaub R. G., Heparin inhibits fibrin, but not leukocytes, in a model of deep-vein thrombosis. Journal of Surgical Research, 1987, 43, 468–475.
6. Butcher E. C., Leukocyte—endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell, 1991, 67, 1033–1036.
7. Frenette P. S., Wagner D. D., Adhesion molecules — Part II: Blood vessels and blood cells. New England Journal of Medicine, 1996, 335, 43–45.
8. Savage B., Saldivar E., Ruggeri Z. M., Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell, 1996, 84, 289–297.
9. Lasky L. A., Lectin cell adhesion molecules (LEC-CAMs): A new family of cell adhesion proteins involved with inflammation. Journal of Cellular Biochemistry, 1991, 45, 139–146.
10. Hattori R., Hamilton K. K., Fugate R. D., McEver R. P., Sims P. J., Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. Journal of Biological Chemistry, 1989, 264, 7768–7771.
11. Geng J.-G., Bevilacqua M. P., Moore K. L., et al, Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature, 1990, 343, 757–760.
12. Sugama Y., Tiruppathi C., Janakidevi K., Andersen T. T., Fenton J. W., Malik A. B., Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: A mechanism for stabilizing neutrophil adhesion. Journal of Cell Biology, 1992, 119, 935–944.
13. Todderud G., Alford J., Aruffo A., Tramposch K. M., Phorbol ester-induced upregulation of polymoronuclear leucocyte P-selectin ligand expression. Cellular Immunology, 1995, 166, 16–24.
14. Weller A., Isenmann S., Vestweber D., Cloning of the mouse endothelial selectins. Expression of both E- and P-selectin is inducible by tumor necrosis factor α. Journal of Biological Chemistry, 1992, 267, 15176–15183.
15. Detmers P. A., Lo S. K., Olsen-Egbert E., Walz A., Baggiolini M., Cohn Z. A., Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leucocyte adhesion receptor CD11b/CD18 on human neutrophils. Journal of Experimental Medicine, 1990, 171, 1155–1162.
16. Detmers P. A., Powell D. E., Walz A., Clark-Lewis I., Baggiolini M., Cohn Z. A., Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leucocyte adhesion and phagocytes. Journal of Immunology, 1991, 147, 4211–4217.
17. Lorant D. E., McEver R. P., McIntrye T. M., Moore K. L., Prescott S. M., Zimmerman G. A., Activation of polymorphonuclear leukocytes reduces their adhesion to P-selectin and causes redistribution of ligands for P-selectin on their surfaces. Journal of Clinical Investigation, 1995, 96, 171–182.
18. Marlin S. D., Springer T. A., Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell, 1987, 51, 813–819.
19. Dustin M. L., Rothlein R., Bhan A. K., Dinarello C. A., Springer T. A., Induction of IL 1 and interferon-gamma: Tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). Journal of Immunology, 1986, 137, 245–254.
20. Pober J. S., Gimbrone M. A., Lapierre L. A., et al, Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. Journal of Immunology, 1986, 137, 1893–1896.
21. Springer T. A., Dustin M. L., Kishimoto T. K., Marlin S. D., The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: Cell adhesion receptors of the immune system. Annual Review of Immunology, 1987, 5, 223–252.
22. Dustin M. L., Staunton D. E., Springer T. A., Supergene families meet in the immune system. Immunology Today, 1988, 9, 213–215.
23. Dustin M. L., Springer T. A., Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. Journal of Cell Biology, 1988, 107, 321–331.
24. Springer T. A., Adhesion receptors of the immune system. Nature, 1990, 346, 425–434.
25. Simmons D., Makgoba M. W., Seed B., ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature, 1988, 331, 624–627.
26. Altman D. M., Hogg N., Trowsdale J., Wilkinson D., Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature, 1989, 338, 512–514.
27. Furie M. B., Tancinco M. C., Smith C. W., Monoclonal antibodies to leucocyte integrins CD11a/CD18 and CD11b/CD18 or intercellular adhesion molecule-1 inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro. Blood, 1991, 78, 2089–2097.
28. Carlos T. M., Harlan J. M., Leukocyte—endothelial adhesion molecules. Blood, 1994, 84, 2068–2101.
29. Vaporciyan A. A., DeLisser H. M., Yan H.-C., et al, Involvement of platelet—endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science, 1993, 262, 1580–1582.
30. Elices M. J., Osborn L., Takada Y., et al, VCAM-1 on activated endothelium interacts with the leucocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell, 1990, 60, 577–584.
31. Marlor C. W., Webb D. L., Bombara M. P., Greve J. M., Blue M. L., Expression of vascular cell adhesion molecule-1 in fibroblast-like synoviocytes after stimulation with tumor necrosis factor. American Journal of Pathology, 1992, 140, 1055–1060.
32. Birdsall H. H., Lane C., Ramser M. N., Anderson D. C., Induction of VCAM-1 and ICAM-1 on human neural cells and mechanisms of mononuclear leucocyte adherence. Journal of Immunology, 1992, 148, 2717–2723.
33. Schleimer R. P., Sterbinsky S. A., Kaiser J., et al, IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. Journal of Immunology, 1992, 148, 1086–1092.
34. Hemler M. E., VLA proteins in the integrin family: Structure, functions and their role on leukocytes. Annual Review of Immunology, 1990, 8, 365–400.
35. Swelick R. A., Lee K. H., Li L. J., Sepp N. T., Caughman S. W., Lawley T. J., Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. Journal of Immunology, 1990, 149, 698–705.
36. Miller M. D., Krangel M. S., Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines. Critical Reviews in Immunology, 1992, 12, 17–46.
37. Baggiolini M., Dewald B., Walz A., Interleukin-8 and related chemotactic cytokines. In Inflammation, Basic Principles and Clinical Correlates, ed. Gallin J. I., Goldstein I. M., Snyderman R., Raven Press, New York, 1992, pp. 247–263.
38. Baggiolini M., Walz A., Kunkel S. L., Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. Journal of Clinical Investigation, 1989, 84, 1045–1049.
39. Matsushima K., Oppenheim J. J., Interluekin 8 and MCAF: Novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine, 1989, 1, 2–13.
40. Oppenhein J. J., Zachariae O. C., Mukaida N., Matsushima K., Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annual Review of Immunology, 1991, 9, 617–648.
41. Kennedy J., Kelner G. S., Kleyensteuber S., et al, Molecular cloning and functional characterization of human lyphotactin. Journal of Immunology, 1995, 155, 203–209.
42. Uguccioni M., Loetscher P., Forssmann U., Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. Journal of Experimental Medicine, 1996, 183, 2379–2384.
43. Ponath P. D., Qin S., Ringer D. J., et al, Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. Journal of Clinical Investigation, 1996, 97, 604–612.
44. Daugherty B. L., Siciliano S. J., DeMartino J. A., Malkowitz L., Sirotina A., Springer M. S., Cloning, expression, and characterization of the human eosinophil eotaxin receptor. Journal of Experimental Medicine, 1996, 183, 2349–2354.
45. Esmon N. L., Esmon C. T., Protein C and the endothelium. Seminars in Thrombosis Hemostasis, 1988, 14, 210–215.
46. Nawroth P. P., Stem D. M., Modulation of endothelial cell hemostatic properties by tumor necrosis factor. Journal of Experimental Medicine, 1986, 163, 740–745.
47. Bevilacqua M. P., Pober J. S., Majeau G. R., Fiers W., Cotran R. S., Gimbrone M. A., Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1. Proceedings of the National Academy of Sciences USA, 1986, 83, 4533–4537.
48. Conway E. M., Bac R., Rosenberg R. D., Konigsberg W. H., Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thrombosis Research, 1989, 53, 231–241.
49. Schleef R. R., Bevilacqua M. P., Sawdey M., Gimbrone M. A., Loskutoff D. J., Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type I plasminogen activator inhibitor. Journal of Biological Chemistry, 1988, 263, 5797–5803.
50. Van Hinsbergh V. W., Kooistra T., Van Den Berg E. A., Princen H. M., Fiers W., Emeis J. J., Tumor necrosis factor increases production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood, 1988, 72, 1467–1473.
51. Medina R., Socher S. H., Han H. J., Friedman P. A., Interleukin-1, endotoxin, or tumor necrosis factor/cachectin enhance the level of plasminogen activator inhibitor messenger RNA in bovine aortic endothelial cells. Thrombosis Research, 1989, 54, 41–52.
52. Herbert C. A., Baker J. B., Interleukin-8: A review. Cancer Investigations, 1993, 11, 743–750.
53. Padrines M., Wolf M., Walz A., Baggiolini M., Interleukin-8 processing by neutrophil elastase, cathespin G, and proteinase-3. FEBS Letters, 1994, 352, 231–235.
54. Koch A. E., Polverini P. J., Kunkel S. L., et al, Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science, 1992, 258, 1798–1801.
55. Herbert C. A., Luscinskas F. W., Kiely J. M., et al, Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. Journal of Immunology, 1990, 145, 3033–3040.
56. Schroder J. M., The monocyte-derived neutrophil activating peptide (NAP/interleukin-8) stimulates human neutrophil arachidonate-5 lipoxygenase, but not the release of cellular arachidonate. Journal of Experimental Medicine, 1989, 170, 847–863.
57. Strieter R. M., Kasahara K., Allen R. M., et al, Cytokine-induced neutrophil-derived interluekin-8. American Journal of Pathology, 1992, 141, 397–407.
58. Fogh K., Larsen C. G., Iversen L., Kragballe K., Interleukin-8 stimulates the formation of 15-hydroxy-eicosatetraenoic acid from human neutrophils in vitro. Agents Actions, 1992, 35, 227–231.
59. Bussolino F., Sironi M., Bocchietto E., Mantovani A., Synthesis of platelet-activating factor by polymorphonuclear neutrophils stimulated with interleukin-8. Journal of Biological Chemistry, 1992, 267, 14598–14603.
60. McDonald P. P., Pouliot M., Borgeat P., McColl S. R., Induction by chemokines of lipid mediator synthesis in granulocyte-macrophage colony-stimulating factor-treated human neutrophils. Journal of Immunology, 1993, 151, 6399–6409.
61. McCain W., Holden E. P., Blackwell T. R., Christman J. W., Leukotriene B4 stimulates human polymorphonuclear leukocytes to synthesize and release interleukin-8 in vitro. American Journal of Respiratory Cellular Molecular Biology, 1994, 10, 651–657.
62. Walz A., Burgener R., Car B., Baggiolini M., Kunkel S. L., Strieter R. M., Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin-8. Journal of Experimental Medicine, 1991, 174, 1355–1362.
63. Clark-Lewis I., Dewald B., Geiser T., Moser B., Baggiolini M., Platelet factor 4 binds to interluekin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proceedings of the National Academy of Sciences USA, 1993, 90, 3574–3577.
64. Leonard E. J., Skeel A., Yoshimura T., Biological aspects of monocyte chemoattractant protein-1 (MCP-1). Advances in Experimental Medicinal Biology, 1991, 305, 57–64.
65. Carr M. W., Roth S. J., Luther E., Rose S. S., Springer T. A., Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proceedings of the National Academy of Sciences USA, 1994, 91, 3652–3656.
66. Loetscher P., Seitz M., Clark-Lewis I., Baggiolini M., Moser B., Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes. FASEB Journal, 1994, 8, 1055–1060.
67. Taub D. D., Proost P., Murphy W. J., et al, Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. Journal of Clinical Investigation, 1995, 95, 1370–1376.
68. Wang J. M., Sica A., Peri G., et al, Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arteriosclerosis and Thrombosis, 1991, 11, 1166–1174.
69. Strieter R. M., Wiggins R., Phan S. H., et al, Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochemical and Biophysical Research Communications, 1989, 162, 694–700.
70. Sica A., Wang J. M., Colotta F., et al, Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. Journal of Immunology, 1990, 144, 3034–3038.
71. Wolpe S. D., Cerami A., Macrophage inflammatory proteins 1 and 2: Members of a novel superfamily of cytokines. FASEB Journal, 1989, 3, 2565–2573.
72. Schall T. J., Bacon K., Toy K. J., Goeddel D. V., Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature, 1990, 347, 669–671.
73. Palabrica T., Lobb R., Furie B. C., et al, Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature, 1992, 359, 848–851.
74. Wakefield T. W., Wrobleski S. K., Sarpa M. S., et al, Deep venous thrombosis in the baboon: An experimental model. Journal of Vascular Surgery, 1991, 14, 588–598.
75. Wakefield T. W., Strieter R. M., Wilke C. A., et al, Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arteriosclerosis Thrombosis and Vascular Biology, 1995, 15, 258–268.
76. Wakefield T. W., Strieter R. M., Downing L. J., et al, P-selectin and TNF inhibition reduces venous thrombosis inflammation. Journal of Surgical Research, 1996, 64, 26–31.
77. Simmons D., Makgoba M. W., Seed B., ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature, 1981, 331, 624–627.
78. Altmann D. M., Hogg N., Trowsdale J., Wilkinson D., Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature, 1989, 338, 512–514.
79. Carden D. L., Young J. A., Granger D. N., Pulmonary microvascular injury after intestinal ischemia-reperfusion: Role of P-selectin. Journal of Applied Physiology, 1993, 75, 2529–2534.
80. Yeo E. L., Sheppard J. A., Fuerstein I. A., Role of P-selectin and leucocyte activation in polymorphonuclear cell adhesion to surface adherent activated platelets under physiologic shear conditions (an injury vessel wall model). Blood, 1994, 83, 2498–2507.
81. Kishimoto T. K., Jutila M. A., Berg E. L., Butcher E. C., Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science, 1989, 245, 1238–1241.
82. Harris N. R., Granger D. N., Leukocytes contribute to increased capillary filtration induced by inflammatory mediators. FASEB Journal, 1993, 7, A887 (abstract).
83. Kurose I., Kubes P., Wolf R., et al, Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circulation Research, 1993, 73, 164–171.
84. Murohara T., Parkinson S. J., Waldman S. A., Lefer A. M., Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Role of protein kinase C. Arteriosclerosis Thrombosis and Vascular Biology, 1995, 15, 2068–2075.
85. Celi A., Pellegrini G., Lorenzet R., et al, P-selectin induces the expression of tissue factor on monocytes. Proceedings of National Academy of Science USA, 1994, 91, 8767–8771.
86. Kirchhofer D., Baumgartner H. R., P-selectin mediates leukocyte adhesion to a collagen-adherent platelet monolayer and platelet thrombi in flowing human blood. Blood, 1995, 86, 2208 (abstract).
87. Iacoviello L., Kolpakov V., Salvatore L., et al, Human endothelial cell damage by neutrophil-derived cathepsin G. Role of cytoskeleton rearrangement and matrix-bound plasminogen activator inhibitor-1. Arteriosclerosis Thrombosis and Vascular Biology, 1995, 15, 2037–2046.
88. Weyrich A. S., McIntyre T. M., McEver R. P., Prescott S. M., Zimmerman G. A., Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-α section. Signal integration and NF-κB translocation. Journal of Clinical Investigation, 1995, 95, 2297–2303.
89. Downing L. J., Wakefield T. W., Strieter R. M., et al, Anti-P-selectin antibody decreases inflammation and thrombus formation in deep venous thrombosis. Journal of Vascular Surgery (in press).
90. Wakefield T. W., Greenfield L. J., Rolfe M. W., et al, Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis. Thrombosis and Haemostasis, 1993, 69, 164–172.
91. Esmon C. T., Taylor F. B., Snow T. R., Inflammation and coagulation: Linked processes potentially regulated through a common pathway mediated by protein C. Thrombosis and Haemostasis, 1991, 66, 160–165.
92. Lee W. P., Gribling P., DeGuzman L., Ehsani N., Watson S. R., A P-selectin-immunoglobulin G chimera is protective in a rabbit ear model of ischemia-reperfusion. Surgery, 1995, 117, 458–465.
93. Hanson S. R., Griffin J. H., Harker L. A., Kelly A. B., Esmon C. T., Gruber A., Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. Journal of Clinical Investigation, 1993, 92, 2003–2012.
94. Dawes J., Interaction of heparins in the vascular environment. Haemostasis, 1993, 23, 212–219.
95. Rao A. K., Niewiarowski S., James P., et al, Effect of heparin on the in vivo release and clearance of human platelet factor 4. Blood, 1983, 61, 1208–1214.
96. Gorski A., Wasik M., Nowaczy K. M., Korczak-Kowalska G., Immunomodulating activity of heparin. FASEB Journal, 1991, 5, 2287–2291.
97. Tangelder G. J., Arfos K. E., Inhibition of leucocyte rolling by protamine and sulfated polysaccharides. Blood, 1991, 77, 1565–1571.
98. Ritchie H., Jamieson A., Booth N. A., Thrombin modulates synthesis of plasminogen activator inhibitor type 2 by human peripheral blood monocytes. Blood, 1995, 86, 3428–3435.
99. DeCaterina R., Libby P., Peng H.-B., et al, Nitric oxide decreases cytokine-induced endothelial activation. Journal of Clinical Investigation, 1995, 96, 60–68.